[AQST] YoY Quarter Result on 30-Sep-2024 [#Q3]

Stock
[AQST] Aquestive Therapeutics, Inc.
Announcement Date
04-Nov-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- -319.27%
YoY- -465.55%
Quarter Report
AQST's Result
AQST's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 13,542 13,002 11,463 13,287 8,260 12,418 13,267 0.34%
PBT -11,509 -2,175 -12,536 -14,555 -16,551 -18,412 -15,038 -4.35%
Tax 0 -140 5 -1 8 2,652 1,932 -
NP -11,509 -2,035 -12,536 -14,555 -16,551 -18,412 -15,038 -4.35%
Tax Rate - - - - - - - -
Total Cost 25,051 15,037 23,999 27,842 24,811 30,830 28,305 -2.01%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin -84.99 -15.65 -109.36 -109.54 -200.38 -148.27 -113.35 -4.68%
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -0.13 -0.03 -0.23 -0.37 -0.49 -0.74 -0.64 -23.31%
EPS Diluted -0.13 -0.03 -0.23 -0.37 -0.49 -0.74 -0.64 -23.31%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.